Borgatta L, Betstadt SJ, Reed A, et al. Relationship of intraamniotic digoxin to fetal demise. Contraception 2010;81:328–330.
358.
Gemzell-Danielsson K, Lalitkumar S. Second trimester medical abortion with mifepristone-misoprostol and misoprostol alone: a review of methods and management. Reprod Health Matters 2008;16(31 Suppl):162–172.
359.
Jain JK, Mishell DR. A comparison of intravaginal misoprostol with prostaglandin E for termination of second trimester pregnancy. N Engl J Med 1994;331:290–293.
360.
Ashok PW, Templeton A, Wagaarachchi PT, et al. Midtrimester medical termination of pregnancy: a review of 1002 consecutive cases. Contraception 2004;69:51–58.
361.
Webster D, Penny GC, Templeton K. A comparison of 600 and 200 mg mifepristone prior to second trimester abortion with the prostaglandin misoprostol. BJOG 1996;103:706–709.
362.
Royal College of Obstetricians. The care of women requesting induced abortion. Guidelines No. 7. London: Royal College of Obstetricians, 2004.
363.
Chai J, Tang OS, Hong QQ, et al. A randomized trial to compare two dosing intervals of misoprostol following mifepristone administration in second trimester medical abortion. Hum Reprod 2009;24:320– 324.
364.
Royal College of Obstetricians and Gynaecologists. Termination of pregnancy for fetal abnormality in England, Scotland and Wales. London: RCOG, 1996.
365.
Hern WM. Laminaria, induced fetal demise and misoprostol in late abortion. Int J Gynaecol Obstet 2001;75:279–286.
366.
Winkler CL, Gray SE, Hauth JC, et al. Mid-second-trimester labor induction: concentrated oxytocin compared with prostaglandin E2 suppositories. Obstet Gynecol 1991;77:297–300.
367.
Frick AC, Drey EA, Diedrich JT, et al. Effect of prior cesarean delivery on risk of second-trimester surgical abortion complications. Obstet Gynecol 2010;115:760–764.
368.
Dickenson JE. Misoprostol for second-trimester pregnancy termination in women with a prior cesarean delivery. Am J Obstet Gynecol 2005;105:352–356.
369.
Evans MI, Berkowitz RI, Wapner RJ, et al. Improvements in outcomes of multifetal pregnancy reduction with increased experience. Am J Obstet Gynecol 2001;184:97–103.
370.
Evans MI, Goldberg JD, Horenstein J, et al. Selective termination for structural, chromosomal and mendelian anomalies: international experience. Am J Obstet Gynecol 1999;82:61–66.
371.
He ZM, Fang Q, Yang YZ, et al. Fetal reduction by bipolar cord coagulation in managing complicated monochorionic multiple pregnancies: preliminary experience in China. Chin Med J (Engl) 2010;123:549–554.
372.